MX2013013243A - Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells. - Google Patents
Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells.Info
- Publication number
- MX2013013243A MX2013013243A MX2013013243A MX2013013243A MX2013013243A MX 2013013243 A MX2013013243 A MX 2013013243A MX 2013013243 A MX2013013243 A MX 2013013243A MX 2013013243 A MX2013013243 A MX 2013013243A MX 2013013243 A MX2013013243 A MX 2013013243A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- hydrostatic pressure
- cancer
- tumor cells
- high hydrostatic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
Abstract
Disclosed are pharmaceutical compositions for inducing an immune response against tumor cells comprising tumor cells which are made apoptotic by treatment with high hydrostatic pressure and dendritic cells, and methods for producing such compositions.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161504387P | 2011-07-05 | 2011-07-05 | |
EP11172622A EP2543386A1 (en) | 2011-07-05 | 2011-07-05 | Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure |
PCT/EP2012/062950 WO2013004708A1 (en) | 2011-07-05 | 2012-07-04 | Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2013013243A true MX2013013243A (en) | 2014-05-30 |
Family
ID=50023029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013013243A MX2013013243A (en) | 2011-07-05 | 2012-07-04 | Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells. |
Country Status (7)
Country | Link |
---|---|
JP (1) | JP6235085B2 (en) |
CL (1) | CL2013003282A1 (en) |
CY (1) | CY1115803T1 (en) |
HR (1) | HRP20141230T1 (en) |
IL (2) | IL229702A (en) |
MX (1) | MX2013013243A (en) |
ZA (1) | ZA201307886B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112014009346B1 (en) | 2011-10-17 | 2020-09-15 | Massachusetts Institute Of Technology | INTRACELLULAR DELIVERY |
US10124336B2 (en) | 2013-08-16 | 2018-11-13 | Massachusetts Institute Of Technology | Selective delivery of material to cells |
JP2017533702A (en) | 2014-10-31 | 2017-11-16 | マサチューセッツ インスティテュート オブ テクノロジー | Delivery of biomolecules to immune cells |
EP3218492A4 (en) | 2014-11-14 | 2018-10-10 | Massachusetts Institute Of Technology | Disruption and field enabled delivery of compounds and compositions into cells |
CN107250373A (en) | 2015-01-12 | 2017-10-13 | 麻省理工学院 | The gene editing realized is delivered by microfluid |
CA2988996A1 (en) | 2015-07-09 | 2017-01-12 | Massachusetts Institute Of Technology | Delivery of materials to anucleate cells |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002504322A (en) * | 1998-02-20 | 2002-02-12 | ザ ロックフェラー ユニバーシティー | Apoptotic cell-mediated antigen presentation to dendritic cells |
US8420078B2 (en) * | 2005-03-10 | 2013-04-16 | Yeda Research And Development Co. Ltd. | Methods and immunogenic cell preparations for treating antigen-associated diseases |
-
2012
- 2012-07-04 MX MX2013013243A patent/MX2013013243A/en active IP Right Grant
-
2013
- 2013-10-22 ZA ZA2013/07886A patent/ZA201307886B/en unknown
- 2013-11-14 CL CL2013003282A patent/CL2013003282A1/en unknown
- 2013-11-28 IL IL229702A patent/IL229702A/en active IP Right Grant
-
2014
- 2014-12-05 CY CY20141101015T patent/CY1115803T1/en unknown
- 2014-12-17 HR HRP20141230AT patent/HRP20141230T1/en unknown
-
2016
- 2016-08-04 JP JP2016153454A patent/JP6235085B2/en active Active
- 2016-09-12 IL IL24778116A patent/IL247781B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CY1115803T1 (en) | 2017-01-25 |
IL247781A0 (en) | 2016-11-30 |
IL247781B (en) | 2019-11-28 |
IL229702A (en) | 2016-09-29 |
IL229702A0 (en) | 2014-01-30 |
ZA201307886B (en) | 2015-03-25 |
HRP20141230T1 (en) | 2015-02-13 |
CL2013003282A1 (en) | 2014-10-10 |
JP2017025066A (en) | 2017-02-02 |
JP6235085B2 (en) | 2017-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA111738C2 (en) | METHOD OF ACTIVE CANCER IMMUNOTHERAPY BY CANCER BY USING TUMOR CELLS DESTROYED BY HIGH HYDROSTATIC TISCODINE | |
PH12019501959A1 (en) | Therapeutic rna | |
PH12018502429A1 (en) | Antibody molecules for cancer treatment | |
MX2018015853A (en) | Multispecific antibodies against cd40 and cd137. | |
PH12017500787A1 (en) | Methods of selecting t cell line and donor thereof for adoptive cellular therapy | |
MX2022003698A (en) | Nanoparticle compositions and methods for immunotherapy. | |
MX2019002979A (en) | Antibody formulations. | |
MX2015001871A (en) | Natural killer cells and uses thereof. | |
NZ739133A (en) | Cellular targeted active ingredient delivery system | |
MX2013013243A (en) | Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells. | |
MX342995B (en) | Methods of generating natural killer cells. | |
MX359769B (en) | Methods of decellularizing bone. | |
CL2018001108A1 (en) | Compositions and methods for tumor transduction | |
EP2670763A1 (en) | Certain chemical entities, compositions, and methods | |
PH12017500406A1 (en) | Novel anti-mfi2 antibodies and methods of use | |
MX2015017959A (en) | Compositions and methods for immunotherapy. | |
EP3998341A3 (en) | Adenoviral vectors | |
AU2018253600A1 (en) | Dosage forms and therapeutic uses of l-4-chlorokynurenine | |
AU2014249346A8 (en) | High purity ovarian cancer stem cells for active autologous immune therapy | |
MX2018000052A (en) | Compositions and methods for combination therapy with dengue virus and dendritic cells. | |
MX2013003859A (en) | Picropodophyllin polymorphs b or c for use in cancer therapy. | |
MX350868B (en) | MEDICAMENTS and METHODS FOR TREATING CANCER. | |
TH149241B (en) | Methods and methods for active cellular immunotherapies. To cure cancer By using tumor cells which were killed by high hydrostatic pressure And dendrite cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |